Zevra Therapeutics Inc (ZVRA)

NASDAQ · Pharmaceuticals

12.01
+0.44 (+3.80%)
Updated Aug 19, 6:39 PM ET
AI Rating
Sell
Overall Score
39
Trend
32
Momentum
57
Risk
24

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Zevra Therapeutics Inc is trading at $12.01, up 3.80% on the session. The 50 day average sits at $12.25 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 48.8, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $10.36 with resistance near $11.93, so that band frames the current range. Average daily movement is roughly $0.63, or about 5.2% of the share price, which is what any stop placement has to allow for. The overall health score of 39 out of 100 combines a trend score of 32, momentum of 57 and a risk score of 24.

Technical indicators

RSI (14)
48.8
neutral
MACD
-0.250
bullish crossover
SMA 20
10.92
SMA 50
12.25
SMA 200
--
unknown
ATR (14)
0.63
avg daily range
Support
10.36
Resistance
11.93
Volume vs 20d
0.53x
below average
Volatility
116.6%
annualised
1 month
-11.29%
3 months
-2.92%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.